Alendronate less effective than Teriparatide for steroid-induced osteoporosisA recent study has determined that Teriparatide, a synthetic form of the human parathyroid hormone, could be used to effectively treat steroid-induced osteoporosis.

It was found by the involved researchers that osteoporosis patients when treated with teriparatide for a period of 36 months had a greater increase in BMD (bone mineral density) and fewer new vertebral fractures than those treated with alendronate.

The findings of this study were published in an issue of Arthritis & Rheumatism, a journal of the American College of Rheumatology (ACR).